Axogen AXGN U.S. — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Axogen in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axogen's u.s. — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axogen's U.S. — revenue?
- Axogen (AXGN) reported U.S. — revenue of $60.13M in Q1 2026.
- How has Axogen's U.S. — revenue changed year-over-year?
- Axogen's U.S. — revenue increased by 25.7% year-over-year, from $47.84M to $60.13M.
- What does U.S. — revenue mean?
- This metric represents the total gross sales generated from products and services sold within the United States geographic market. It serves as a primary indicator of the company's commercial penetration, market adoption, and revenue growth trajectory within its core domestic territory. Tracking this figure allows investors to assess the effectiveness of regional sales strategies and the overall demand for nerve repair technologies in the domestic healthcare sector.